Abstract
Most patients with COVID-19 exhibit mild to moderate respiratory symptoms; however, some develop severe pneumonia and hypoxemia is a frequent cause of death. Severely ill COVID-19 patients often require endotracheal intubation and mechanical ventilation. The choice of drugs to sedate these patients differs widely depending on drug availability and clinical expertise. We suggest that care providers with the appropriate clinical expertise, consider the use of inhalational anesthetic drugs, such as sevoflurane and isoflurane for the following reasons.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
